Cargando…
Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients’ and Clinicians’ Experiences
BACKGROUND: The benefits of electronic patient reported outcomes (PRO) questionnaires have been demonstrated in many settings, including in hospitals and patient homes. However, it remains to be investigated how melanoma patients and their treating clinicians experience the electronic self-reporting...
Autores principales: | Tolstrup, Lærke K, Pappot, Helle, Bastholt, Lars, Zwisler, Ann-Dorthe, Dieperink, Karin B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180512/ https://www.ncbi.nlm.nih.gov/pubmed/32271150 http://dx.doi.org/10.2196/14896 |
Ejemplares similares
-
Selection of patient reported outcomes questions reflecting
symptoms for patients with metastatic melanoma receiving immunotherapy
por: Tolstrup, Lærke K., et al.
Publicado: (2019) -
The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy: a randomized controlled pilot trial
por: Tolstrup, Lærke K., et al.
Publicado: (2020) -
Danish translation, cultural adaption and initial psychometric evaluation of the patient feedback form
por: Tolstrup, Lærke K., et al.
Publicado: (2018) -
Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized controlled trial
por: Tolstrup, Lærke K., et al.
Publicado: (2022) -
The cost of living with cancer during the second wave of COVID-19: A mixed methods study of Danish cancer patients' perspectives
por: Dieperink, Karin Brochstedt, et al.
Publicado: (2021)